Patient Management Services

SynCardia Total Artificial Heart (TAH) patients are effectively heart transplant recipients with four mechanical valves. They have a near-normal CVP, normal physiology and the source of their heart failure has been eliminated through biventricular replacement. In addition, there are no inotropes or anti-rejection medications needed. TAH patients benefit from high cardiac output, typically 7 L/min ±1 for the 70cc TAH (max: 9.5 L/min) and 5 L/min ±1 for the 50cc TAH (max: 7.5 L/min). When patients exercise, there is never a need to adjust the driver settings, as cardiac output will change based on the patient’s activity level.